Smith & Nephew SNATS Net Income 2010-2024 | SNN

Smith & Nephew SNATS annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Smith & Nephew SNATS net income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS net income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS annual net income for 2024 was $0.412B, a 56.65% increase from 2023.
  • Smith & Nephew SNATS annual net income for 2023 was $0.263B, a 17.94% increase from 2022.
  • Smith & Nephew SNATS annual net income for 2022 was $0.223B, a 57.44% decline from 2021.
Smith & Nephew SNATS Annual Net Income
(Millions of US $)
2024 $412
2023 $263
2022 $223
2021 $524
2020 $448
2019 $600
2018 $663
2017 $767
2016 $784
2015 $410
2014 $501
2013 $556
2012 $729
2011 $582
2010 $615
2009 $472
Smith & Nephew SNATS Quarterly Net Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 $160
2014-09-30 $102
2014-06-30 $89
2014-03-31 $150
2013-12-31 $162
2013-09-30 $122
2013-06-30 $129
2013-03-31 $143
2012-12-31 $142
2012-09-30 $134
2012-06-30 $292
2012-03-31 $161
2011-12-31 $140
2011-09-30 $133
2011-06-30 $153
2011-03-31 $156
2010-12-31 $182
2010-09-30 $137
2010-06-30 $137
2010-03-31 $159
2009-12-31 $128
2009-09-30 $128
2009-06-30 $118
2009-03-31 $98
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.087B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $209.668B 24.59
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Medtronic (MDT) Ireland $114.826B 16.28
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Baxter (BAX) United States $14.312B 10.69
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Phibro Animal Health (PAHC) United States $1.205B 15.40
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00